hrcak mascot   Srce   HID

Pregledni rad

Vasoactive Agents

Ino Husedzinovic ; Department for anesthesiology, reanimatology and intensive care medicine; University Hospital Dubrava; Gojko Susak Avenue No 6; 10000 Zagreb, Croatia
Nikola Bradic ; Department for anesthesiology, reanimatology and intensive care medicine; University Hospital Dubrava; Gojko Susak Avenue No 6; 10000 Zagreb, Croatia
Tanja Goranovic ; Department for anesthesiology, reanimatology and intensive care medicine; University Hospital Dubrava; Gojko Susak Avenue No 6; 10000 Zagreb, Croatia

Puni tekst: engleski, pdf (68 KB) str. 9-12 preuzimanja: 2.043* citiraj
APA 6th Edition
Husedzinovic, I., Bradic, N. i Goranovic, T. (2006). Vasoactive Agents. Signa vitae, 1 (1), 9-12. Preuzeto s https://hrcak.srce.hr/11955
MLA 8th Edition
Husedzinovic, Ino, et al. "Vasoactive Agents." Signa vitae, vol. 1, br. 1, 2006, str. 9-12. https://hrcak.srce.hr/11955. Citirano 30.03.2020.
Chicago 17th Edition
Husedzinovic, Ino, Nikola Bradic i Tanja Goranovic. "Vasoactive Agents." Signa vitae 1, br. 1 (2006): 9-12. https://hrcak.srce.hr/11955
Harvard
Husedzinovic, I., Bradic, N., i Goranovic, T. (2006). 'Vasoactive Agents', Signa vitae, 1(1), str. 9-12. Preuzeto s: https://hrcak.srce.hr/11955 (Datum pristupa: 30.03.2020.)
Vancouver
Husedzinovic I, Bradic N, Goranovic T. Vasoactive Agents. Signa vitae [Internet]. 2006 [pristupljeno 30.03.2020.];1(1):9-12. Dostupno na: https://hrcak.srce.hr/11955
IEEE
I. Husedzinovic, N. Bradic i T. Goranovic, "Vasoactive Agents", Signa vitae, vol.1, br. 1, str. 9-12, 2006. [Online]. Dostupno na: https://hrcak.srce.hr/11955. [Citirano: 30.03.2020.]

Sažetak
This article is a short review of vasoactive drugs which are in use in todays clinical practice. In the past century, development of vasoactive drugs went through several phases. All of these drugs are today divided into several groups, depending on their place of action, pharmacological pathways and/or effects on target organ or organ system. Hence, many different agents are today in clinical practice, we have shown comparison between them. These agents provide new directions in the treatment of cardiovascular compromise, suggesting that the primary goal of therapy is to produce a vasodilatory effect of the circulation rather than to reverse hemodynamic failure by using inotropic agents, with their inherent risks and side effects.

Ključne riječi
vasoactive agents; inotropic agents; levosimendan; phosphodiesterase III inhibitors

Hrčak ID: 11955

URI
https://hrcak.srce.hr/11955

Posjeta: 2.397 *